Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies
Crossref DOI link: https://doi.org/10.1186/s13045-016-0380-0
Published Online: 2017-01-11
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schönfeld, Kurt
Zuber, Chantal
Pinkas, Jan
Häder, Thomas
Bernöster, Katrin
Uherek, Christoph http://orcid.org/0000-0001-5579-6964
Funding for this research was provided by:
Biotest AG